Welcome to our dedicated page for Ainos SEC filings (Ticker: AIMDW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ainos's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ainos's regulatory disclosures and financial reporting.
Ainos, Inc. director Tsai Chun-Jung sold a total of 28,800 shares of Common Stock in open-market transactions. The sales occurred at prices of $1.55 and $1.87 per share. A footnote states the shares were sold to cover income tax obligations. After these transactions, Tsai directly holds 658,199 shares.
Ainos, Inc. director Lee Ting-Chuan sold a total of 18,302 shares of Common Stock in open-market transactions on May 21 and 22 at prices of $1.56 and $1.57 per share. A footnote explains that the sales were made to cover income tax obligations, and he continues to own 917,405 shares directly after these trades.
Ainos, Inc. director Chiang Yao-Chung reported two open-market purchases of the company’s common stock through indirect ownership by his spouse. On May 19, his spouse bought 2,200 shares at $1.68 per share, bringing that indirect position to 3,529 shares. On May 18, his spouse bought 500 shares at $1.65 per share, bringing that indirect position to 1,329 shares. A footnote states that, in addition to these indirect holdings, Chiang directly owns 90,880 shares of Ainos common stock.
Ainos, Inc. reported Q1 2026 results showing minimal revenue and continued losses while shoring up liquidity with new financing. Revenue was just $161, down sharply from $106,207 a year earlier as the company shifted AI Nose activity from healthcare-adjacent uses toward earlier-stage industrial deployments.
The net loss narrowed to $2,459,800 from $3,286,022, helped by a 30% reduction in operating expenses, especially lower share-based compensation and SG&A. Cash and cash equivalents rose to $2,841,422 from $417,353 at year-end, driven by a new related-party loan of about $2,812,940 and $601,600 of net proceeds from an at-the-market equity program.
Total liabilities increased to $16,389,637, including $11,000,000 of related-party convertible notes, while stockholders’ equity declined to $5,691,946. Management states that recurring losses, an accumulated deficit of $69,980,128, and dependence on future financings create “substantial doubt” about the company’s ability to continue as a going concern.
Ainos, Inc. reported first quarter 2026 results showing minimal revenue and a narrower loss as it advances its AI Nose commercialization strategy. Revenue for the quarter was $161, compared with $106,207 a year earlier, reflecting the shift toward infrastructure-focused AI Nose deployments still in early stages.
The company reported a net loss of $2.46 million, improving from a $3.29 million loss in the prior-year quarter, as operating expenses declined about 30% year-over-year to approximately $2.28 million. Cash and cash equivalents rose to $2.84 million from $0.42 million, supported by a previously announced NT$90 million (approximately $2.8 million) financing, while total liabilities increased to $16.39 million and stockholders’ equity decreased to $5.69 million.
Operationally, Ainos continued deploying AI Nose under a roughly three-year $2.1 million commercial arrangement in backend semiconductor manufacturing, initiated pilots in front-end semiconductor environments, expanded healthcare infrastructure pilots, and further developed its Smell ID datasets and Smell Language Model to support long-term Smell AI platform commercialization.
Ainos, Inc. director Chiang Yao-Chung reported an open-market purchase of the company’s common stock through an indirect holding. On May 5, 2026, a spouse-related account bought 129 shares at $1.70 per share, bringing this indirect position to 829 shares.
In addition to these indirectly held shares, the reporting person also directly owns 90,880 shares of Ainos common stock as previously disclosed, indicating that the newly reported transaction is small compared with the existing direct holdings.
Ainos, Inc. director Chiang Yao-Chung reported two open-market purchases of the company’s common stock through indirect ownership by his spouse. He bought 100 shares at $1.75 per share on April 29, 2026 and 200 shares at $1.68 per share on April 30, 2026, increasing indirect holdings to 700 shares. A footnote states he also directly owns 90,880 shares of Ainos common stock as previously disclosed.
Ainos, Inc. director TSAI CHUN-JUNG received equity compensation through restricted stock units that immediately converted into common shares. On the transaction date, 330,000 RSUs were granted and vested under the Ainos, Inc. 2023 Stock Incentive Plan and then converted into 330,000 shares of common stock at a stated price of $1.61 per share. Following these transactions, TSAI directly holds 686,999 shares of Ainos common stock. These are compensation-related awards rather than open-market purchases or sales.
Ainos, Inc. director and CEO Tsai Chun-hsien reported equity awards and a conversion on April 15, 2026. He received 300,000 RSUs that vested under the Ainos, Inc. 2023 Stock Incentive Plan, which were then converted into 300,000 shares of Common Stock. A related award entry shows these 300,000 Common shares at $1.61 per share, bringing his directly held Common Stock to 710,372 shares after the transactions. No open-market purchases or sales were reported; all activity reflects compensation-related grants and a derivative conversion.
Ainos, Inc. director Lee Ting-chuan reported equity compensation activity involving restricted stock units (RSUs) that converted into common shares. On April 15, 2026, he received 570,000 RSUs granted and vested under the Ainos, Inc. 2023 Stock Incentive Plan, which were then converted into 570,000 shares of common stock at a reported value of $1.61 per share. After these award and conversion transactions, Lee directly holds 935,707 shares of Ainos common stock. These are compensation-related acquisitions rather than open-market purchases or sales.